Kronične bolezni z vidika multimorbidnosti
Ključne besede:
multimorbodnost, komorbidnost, kronične bolezniPovzetek
V Evropi se soočamo s porastom kroničnih bolezni zaradi starajoče se populacije in tveganj, ki so povezana z življenjskim slogom. Multimorbidnost je pogost problem starajočih se družb z raznovrstnimi in neugodnimi posledicami za posameznike, družbo in zdravstvene sisteme. Prevalenca s starostjo progresivno narašča in multimorbidnost postaja najpogostejše kronično stanje. Multimorbidnost pomembno vpliva na neugodne izide zdravljenja, kvaliteto življenja, hkrati pa je povezana s porastom stroškov zdravstvenih storitev. Ljudje živimo dlje, a z več kroničnimi stanji, kar povečuje potrebe po zdravstveni oskrbi. V staroživih družbah kronične bolezni predstavljajo glavni vzrok obolevnosti in tudi smrtnosti, zato obstaja potreba po stroškovno učinkovitih poteh za oskrbo populacije. Projekt skupnega ukrepanja CHRODIS (Joint Action on Chronic Diseases) je usmerjen v učinkovito zmanjšanje kroničnih bolezni in promocijo zdravega življenja ter aktivnega staranja širom Evrope. Glavni cilji so
promocija zdravega načina življenja, spodbujanje in lajšanje izmenjave in prenosa dobrih izkušenj na področju kroničnih bolezni med državmi EU in regijami, s posebno pozornostjo na promociji zdravja, preventivi kroničnih stanj, multimorbidnosti in sladkorne bolezni.
Literatura
Alonso-Moran, E., Nuno-Solinis, R., Onder, G. et al. (2015a). Multimorbidity in risk stratification tools to predict negative outcomes in adult population. Eur J Intern Med, 26, pp. 182–189.
Alonso-Moran, E., Nuno-Solinis, R., Orueta J. F et al. (2015b). Health-related quality of life and multimorbidity in community-dwelling telecare-assisted elders in the Basque Country. Eur J Intern Med, 26, pp. 169–175.
American Geriatrics Society Expert Panel on the Care of Older Adults with Multimorbidity. (2012). Guiding principles for the care of older adults with multimorbidity: an approach for clinicians. J Am Geriatr Soc, 60, E1.
Banerjee, S. (2015). Multimorbidity-older adults need health care that can comt past one. Lancet. 385, pp. 587–589.
Barnett, K., Mercer, S. W., Norbury, M., et al. (2012). Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancetlul, 380, pp. 37–43.
Boyd, C. and Fortin, M. (2010). Future of multimorbidity research: how should understanding of multimorbidity inform health system design? Public Health Rev, 32, pp. 451–474.
Busse, R., Blümel, M., Scheller-Kreinsen, D. et al. (2010). Tackling chronic disease in Europe. Strategies, interventions and challenges. Observatory Studies Series No. 20. World Health Organization, on behalf of the European Observatory on Health Systems and Policies Series.
Calderon-Larranaga, A., Abad-Diez, J. M., Gimeno-Feliu, L. A. et al. (2015). Global health care use by patients with type-2 diabetes: does the type of comorbidity matter? Eur J Intern Med, 26, pp. 203–210.
Chronic Conditions. (2004) Making the case for ongoing care. September 2004 update. John Hopkins and the Robert Wood Johnson Foundation‘s for Solutions. Pridobljeno dne 1. 10. 2012 s svetovnega spleta: http://www.partnershipforsolutions.org/DMS/files/chronicbook2004.pdf.
Condelius, A., Edberg, A. K., Jakobsson, U. et al. (2008). Hospital admissions among people 65+ related to multimorbidity, municipal and outpatient care. Arch Gerontol Geriatr Jan. 46, pp. 41–55.
Corrao, S., Santalucia, P., Argano, C. et al. (2014). Gender differences in disease distribution and outcome in hospitalized elderly: data from the REPOSI study. Eur J Intern Med, 25, pp. 617–623.
Eurostat, 2014. Pridobljeno dne 1. 12. 2015 s svetovnega spleta: http://epp.eurostat.ec.europa.eu/portal/page/portal/health/public_health/.
Forjaz, M. J., Rodriguez-Blazquez, C., Ayala, A. et al. (2015). Chronic conditions, disability, and quality of life in older adults with multimorbidity in Spain. Eur J Intern Med, 26, pp. 176–181.
Fortin, M., Bravo, G., Hudon, C. et al. (2005). Prevalence of multimorbidity among adults seen in family practice. Annals of family medicine, 3, pp. 223–228.
Fortin, M., Hudon, C., Haggerty, J. et al. (2004). Untagling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci Med Sci, 59, p. 255.
Fortin, M., Hudon, C., Haggerty, J. et al. (2010). Prevalence estimates of multimorbidity: a comperative study of two sources. BMC health Serv Res, 10, p. 111.
Fortin, M., Soubhi, H., Hudon, C. et al. (2007). Multimorbidity‘s many challenges. BMJ, 334, pp. 1016–1017.
Gabrovec, B. (2015). The prevalence of methamphetamine, MDMA and new drugs among opiate addicts on agonist opioid treatment. Heroin addiction and related clinical problems, 17, pp. 69–76.
Gabrovec, B. and Lobnikar, B. (2015). The analysis of the role of an institution in providing safety and quality in psychiatric health care. Anadolu Psikiyatri Dergisi, 16, pp. 420–425.
Gijsen, R., Hoeymans, N., Schellevis, F. G. et al. (2001). Causes and consequences of comorbidity: a review. J Clin Epidemiol, 54, 661–674.
Global Burden of Disease Study 2013 Collaborators. (2015). Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 coutries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet, 386, p. 743.
Glynn, L. G., Valderas, J. M., Healy, P. et al. (2011). The prevalence of multimorbidity in primary care and its effect on health care utilization and cost. Fam Pract, 28, pp. 516–523.
Ha, N. T., Le, N. H., Khanal, V. et al. (2015). Multimorbidity and its social determinants among older people in southern provinces, Vietnam. Int Journ Equity Health, 14, p. 50.
Hopman, P., Heins, M. J., Rijken, M. et al. (2015). Health care utilization of patients with multiple chronic diseases in The Netherlands: differences and underlying factors. Eur J Intern Med, 26, pp. 190–196.
House, J. S., Lantz, P. M. and Herd, P. (2005). Continuity and change in the social stratification of aging and health over the life course: evidence from a nationally representative longitudinal study from 1986 to 2001/2002 (Americans‘ Changing Lives Study). J Gerontol B Psychol Sci Soc Sci, 60, pp. 15–26.
Hsu, H. C. (2015). Trajectories of multimorbidity and impact on successful aging. Experimental Gerontology, 66, pp. 32–38.
Jackson, C. A., Jones, M., Tooth, L. et al. (2015). Multimorbidity patterns are differentially associated with functional ability and decline in a longitudinal cohort of older women. Age and Aging, 4, pp. 810–816.
Landi, F., Liperoti, R., Russo, A. et al. (2010). Disability, more than multimorbidity, was predictive of mortality among older persons aged 80 years and older. J Clin Epidemiol, 63, pp. 752–759.
Laux, G., Kuehlein, T., Rosemann, T. et al. (2008). Co- and multimorbidity patterns in primary care based on episodes of care: results from the German CONTENT project. BMC Health Serv Res, 8, p. 14.
Le Reste, J., Nabbe, P., Lingner, H., et al. (2015). What research agenda could be generated from the European General Practice Research Network concept of Multimorbidity in Family Practice? BMC Fam Pract, 16, p. 125.
Marengoni, A., Angleman, S., Melis, R. et al. (2011). Aging with multimorbidity: a systematic review of the literature. Ageing Res Rev, 10, pp. 430–439.
Marengoni, A., Von Strauss, E., Rizzuto, D. et al. (2009). The impact of chronic multimorbidity and disability on functional decline and survival in elderly persons. A community-based, longitudinal study. J Intern Med, 265, pp. 288–295.
Marengoni, A., Winblad, B., Karp, A. et al. (2008). Prevalence of chronic diseases and multimorbidity among the elderly population in Sweden. Am J Public Health, 98, pp. 1198–1200.
Melis, R., Marengoni, A., Angleman, S. et al. (2014). lncidence and predictors of multimorbidity in the elderly: a population-based longitudinal study. PLoS One, 9, e103120.
Mercer, S. W., Smith, S. M., Wyke, S. et al. (2009). Multimorbidity in primary care: developing the research agenda. Fam Pract, 26, p. 79.
Navickas, R., Visockiene, Z., Puronaite, R. et al. (2015). Prevalence and structure of multiple chronic conditions in Lithuanian population and the distribution of the associated healthcare resources. Eur J Intern Med, 26, pp. 160–168.
Onder, G., Lattanzio, F., Battaglia, M. et al. (2011). The risk of adverse drug reactions in older patients: beyond drug metabolism. Curr Drug Metab, 12, pp. 647–651.
Orueta, J. F., García-Álvarez, A., García-Goñi, M. et al. (2014). Prevalence and costs of multimorbidity by deprivation levels in the basque country: a population based study using health administrative databases. PLoS One, 9, e89787.
Pache, B., Vollenweider, P., Waeber, G. et al. (2015). Prevalence of measured and reported multimorbidity in a representative sample of the Swiss population. BMC public health, 15, p. 1515.
Prince, M. J., Wu, F., Guo, Y. et al. (2015). The burden of disease in older people and implications for health Policy and practice. Lancet, 385.
Rijken, M., Struckmann, V., Dyakova, M., Melchiorre, M. G., Rissanen, S. and Van Ginneken, E. (2013). E. ICARE4EU: improving care for people with multiple chronic conditions in Europe. Eurohealth, 19, No. 3, pp. 29–31
Salisbury, C., Johnson, I., Purdy, S. et al. (2011). Epidemiology and impact of multimorbidity in primary care: a retrospective cohort study. Br J Ger Pract J R Coll Gen Pract, 61, e12–21.
Schäfer, I., Hansen, H., Schön, G. et al. (2012). The influence of age, gender and socio-economic status on multimorbidity patterns in primary care. First results from the multicare cohort study. BMC Health Serv Res, 12, p. 89.
Smith, S. M., Soubhi, H., Fortin, M. et al. (2012). Managing patients with multimorbidity: systematic review of interventions in primary care and community settings. BMI, 345, e5205.
Starfield, B., Lemke, K. W., Herbert, R. et al. (2005). Comorbidity and the use of primary care and specialist care in the elderly. Ann Fam Med, 3, pp. 215–222.
Tinetti, M. E., Fried, T. R. and Boyd, C. M. (2012). Designing health care for the most common chronic condition-multimorbidity. JAMA, 307, pp. 2493–2494.
Uijen, A. A. and Van de Lisdonk, E. H. (2008). Multimorbidity in primary care: prevalence and trend over the last 20 years. Eur J Gen Pract, 14, pp. 28–32.
Van Oostrom, S. H., Picavet, H. S. J., Bruin, S. R. et al. (2014). Multimorbidity of chronic diseases and health care utilization in general practice. BMC Fam Pract, 15, p. 61.
Vogeli, C., Shields, A. E., Lee, T. A., Gibson, T. B., Marder, W. D., Weiss, K. B. et al. (2007). Multiple chronic conditions: prevalence, health consequences, and implications for quality, caremanagement, and costs. J Gen Intern Med, 22, pp. 391–395.
Wikstrom, K., Lindstrom, J., Harald, K. et al. (2015). Clinical and lifestayle-related risks factors for incident multimorbidity: 10-year follow-up of Finnish population-based cohorts 1982-2012. Eur J Intern Med, 26, pp. 211–216.
Wolff, J., Starfield, B. and Anderson, G. (2002). Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med, 162, pp. 2269–2276.
Yanick, R., Ershler, W., Satariano, W. et al. (2007). Report of the national institute on aging task force on comorbidity. J Gerontol A Biol Sci Med Sci, 62, p. 275.
